Pharmacyclics, Inc.
(NASDAQ : PCYC)

( )
PCYC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading PCYC News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.02%126.300.6%$998.79m
PFEPfizer Inc.
-0.25%34.381.9%$823.08m
BMYBristol-Myers Squibb Company
0.00%56.352.8%$652.13m
MRKMerck & Co., Inc.
0.00%63.500.6%$580.86m
ABBVAbbVie, Inc.
0.00%65.511.9%$448.91m
LLYEli Lilly and Company
0.00%84.361.1%$333.39m
NVSNovartis AG Sponsored ADR
-0.26%74.010.2%$226.90m
AZNAstraZeneca PLC Sponsored ADR
0.65%31.181.1%$144.98m
GSKGlaxoSmithKline plc Sponsored ADR
0.02%42.290.3%$117.94m
NVONovo Nordisk A/S Sponsored ADR Class B
-2.48%33.090.1%$71.30m
SNYSanofi Sponsored ADR
-0.46%44.470.2%$63.52m
LCILannett Company, Inc.
0.00%20.8536.7%$15.53m
SCMPSucampo Pharmaceuticals, Inc. Class A
0.00%10.7515.6%$12.98m
AKTXAkari Therapeutics Plc Sponsored ADR
0.00%6.530.1%$0.12m
EPIXESSA Pharma Inc
0.00%3.310.0%$0.03m

Company Profile

Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has three product candidates in clinical development and several preclinical molecules in lead optimization. The company was founded in 1991 and is headquartered in Sunnyvale, CA.